Learn more

NATUREGEN BIOTECHNOLOGY SHANGHAI CO LTD

Overview
  • Total Patents
    54
About

NATUREGEN BIOTECHNOLOGY SHANGHAI CO LTD has a total of 54 patent applications. Its first patent ever was published in 2008. It filed its patents most often in China. Its main competitors in its focus markets biotechnology are LEXOW PREBEN, DNA LOGIX INC and THROMBINOSCOPE B V.

Patent filings in countries

World map showing NATUREGEN BIOTECHNOLOGY SHANGHAI CO LTDs patent filings in countries
# Country Total Patents
#1 China 54

Patent filings per year

Chart showing NATUREGEN BIOTECHNOLOGY SHANGHAI CO LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Biotechnology

Focus technologies

# Technology
#1 Measuring microorganism processes

Top inventors

# Name Total Patents
#1 Zhang Yunfu 33
#2 Qiu Jianying 33
#3 Qiu Lin 33
#4 Zhang Yuli 33
#5 Jianying Qiu 21
#6 Yunfu Zhang 21
#7 Yuli Zhang 15
#8 Lin Qiu 15

Latest patents

Publication Filing date Title
CN104711322A HDAC10 gene in-situ hybridization detection kit, detection method and application thereof
CN104711326A Multi-cancer pathologic evolution early-stage Bmi1 gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711335A Cancer metastasis pathologic evolution early-stage HOPX gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711323A Alzheimer disease early-stage lesion EPHA1 gene mRNA level in-situ hybridization detection kit
CN104711321A Stomach cancer pathologic evolution early-stage miRNA-200c level in-situ hybridization detection kit, detection method and applications thereof
CN104711336A Solid tumor pathologic evolution early-stage GADD45G gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711325A AGPS gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711334A Alzheimer disease early-stage lesion PS-1 gene mRNA level in-situ hybridization detection kit
CN104711330A Alzheimer disease early-stage lesion CR-1 gene mRNA level in-situ hybridization detection kit
CN104711329A Cancer metastasis pathologic evolution early-stage IDH1 gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711320A Alzheimer disease early-stage lesion MS4A4 gene mRNA level in-situ hybridization detection kit
CN104711319A Alzheimer disease early-stage lesion PS-2 gene mRNA level in-situ hybridization detection kit
CN104711331A Cancer pathologic evolution early-stage Gankyrin gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711332A Alzheimer disease early-stage lesion CYP46 gene mRNA level in-situ hybridization detection kit
CN104711327A Cancer pathologic evolution early-stage GPR116 gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711337A HELQ gene mRNA level in-situ hybridization detection kit, detection method and applications thereof
CN104711318A Alzheimer disease early-stage lesion PICALM gene mRNA level in-situ hybridization detection kit
CN104711324A Alzheimer disease early-stage lesion TAU gene mRNA level in-situ hybridization detection kit
CN104711333A TACC3 gene in-situ hybridization detection kit, detection method and application thereof
CN104711328A Alzheimer disease early-stage lesion mRNA level in-situ hybridization detection kit, screening method, and applications thereof